Poloxamer‐linked prodrug of a topoisomerase I inhibitor SN22 shows efficacy in models of high‐risk neuroblastoma with primary and acquired chemoresistance

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 22, 2022
Source ID
10.1096/fj.202101830rr

Entities

People

  • Benjamin B. Pressly
  • Danielle Soberman
  • David T. Guerrero
  • Ferro Nguyen
  • Garrett M Brodeur
  • Ilia Fishbein
  • Ivan S. Alferiev
  • Michael Chorny
  • Peng Guan
  • Venkatadri Kolla

Organizations

  • Alex's Lemonade Stand Foundation
  • CURE Childhood Cancer
  • National Cancer Institute
  • Solving Kids' Cancer
  • United States Department of Defense
  • University of Pennsylvania